 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 04/23/2024 |
$1.56 |
$1.60 |
$1.49 |
$1.50 |
161.30K | | 04/24/2024 |
$1.53 |
$1.58 |
$1.38 |
$1.42 |
319.50K | | 04/25/2024 |
$1.42 |
$1.42 |
$1.30 |
$1.41 |
169.20K | | 04/26/2024 |
$1.40 |
$1.44 |
$1.31 |
$1.36 |
264.40K | | 04/29/2024 |
$1.39 |
$1.48 |
$1.38 |
$1.42 |
155.40K |
|
|
| Cue Biopharma is a clinical-stage biopharmaceutical company. Co.'s proprietary Immuno-Selective Targeting and Alteration of T Cells (Immuno-STAT™) platform, enable Co. to restore health while avoiding the side effects of immune activation in the case of cancer and immune suppression in the case of autoimmune disease. Co. focused its internal resources on drug product candidates in its CUE-100 series of Immuno-STATs. The CUE-100 series uses the selectivity of the T cell receptor combined with rationally engineered interleukin 2 in context of the core Immuno-STAT framework for selective activation of targeted tumor-specific T cells to potentially address a range of cancers. | |
|
Cue Biopharma (CUE) has the following price history information. Looking back at CUE historical stock prices for the last five trading days, on April 23, 2024, CUE opened at $1.56, traded as high as $1.60 and as low as $1.49, and closed at $1.50. Trading volume was a total of 161.30K shares. On April 24, 2024, CUE opened at $1.53, traded as high as $1.58 and as low as $1.38, and closed at $1.42. Trading volume was a total of 319.50K shares. On April 25, 2024, CUE opened at $1.42, traded as high as $1.42 and as low as $1.30, and closed at $1.41. Trading volume was a total of 169.20K shares. On April 26, 2024, CUE opened at $1.40, traded as high as $1.44 and as low as $1.31, and closed at $1.36. Trading volume was a total of 264.40K shares. On April 29, 2024, CUE opened at $1.39, traded as high as $1.48 and as low as $1.38, and closed at $1.42. Trading volume was a total of 155.40K shares.
CUE Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Cue Biopharma shares, starting with a $10,000 purchase of CUE, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
01/03/2018 |
|
| End date: |
04/29/2024 |
|
| Start price/share: |
$12.75 |
|
| End price/share: |
$1.42 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-88.86% |
|
| Average Annual Total Return: |
-29.34% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$1,113.51 |
|
| Years: |
6.32 |
|
|
|
| Date |
Close |
| 04/23/2024 | $1.50 | | 04/24/2024 | $1.42 | | 04/25/2024 | $1.41 | | 04/26/2024 | $1.36 | | 04/29/2024 | $1.42 |
|
|
